Literature DB >> 8723421

Helicobacter pylori, pepsinogens and gastrin: relationship with age and development of atrophic gastritis.

E J Kuipers1, G Pals, A S Peña, C W van Uffelen, A Kok, B D Westerveld, S G Meuwissen.   

Abstract

BACKGROUND: Helicobacter pylori causes chronic gastritis in all infected individuals and thus may be a risk factor for the ultimate development of trophic gastritis and gastric cancer. The serum levels of pepsinogen A, pepsinogen C and gastrin can be used as markers for both non-atrophic and atrophic gastritis.
METHODS: We determined the serum levels of gastrin, pepsinogen A and pepsinogen C and the pepsinogen A/C ratio in 150 H. pylori-negative and 186 H. pylori-positive individuals.
RESULTS: The H. pylori infected patients had significantly higher serum levels of pepsinogen A, pepsinogen C and gastrin and a significantly lower pepsinogen A/C ratio. In the non-infected patients, none of the respective serum values changed with increasing age. In contrast, in the infected patients, the pepsinogen A level and pepsinogen A/C ratio decreased significantly with increasing age.
CONCLUSION: H. pylori infection increases serum levels of pepsinogen A, pepsinogen C and gastrin and decreases the pepsinogen A/C ratio. In infected subjects, levels of pepsinogen A and the pepsinogen A/C ratio decrease with ageing. These findings support the concept of H. pylori as a risk factor for the development of atrophic gastritis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8723421     DOI: 10.1097/00042737-199602000-00012

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  6 in total

1.  Helicobacter pylori stimulates pepsinogen secretion from isolated human peptic cells.

Authors:  S Lorente; O Doiz; M Trinidad Serrano; J Castillo; A Lanas
Journal:  Gut       Date:  2002-01       Impact factor: 23.059

Review 2.  Helicobacter pylori.

Authors:  B E Dunn; H Cohen; M J Blaser
Journal:  Clin Microbiol Rev       Date:  1997-10       Impact factor: 26.132

3.  Serum biomarker tests are useful in delineating between patients with gastric atrophy and normal, healthy stomach.

Authors:  Katsunori Iijima; Yasuhiko Abe; Ryosuke Kikuchi; Tomoyuki Koike; Shuichi Ohara; Pentti Sipponen; Tooru Shimosegawa
Journal:  World J Gastroenterol       Date:  2009-02-21       Impact factor: 5.742

Review 4.  Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers.

Authors:  Lars Agréus; Ernst J Kuipers; Limas Kupcinskas; Peter Malfertheiner; Francesco Di Mario; Marcis Leja; Varocha Mahachai; Niv Yaron; Martijn van Oijen; Guillermo Perez Perez; Massimo Rugge; Jukka Ronkainen; Mikko Salaspuro; Pentti Sipponen; Kentaro Sugano; Joseph Sung
Journal:  Scand J Gastroenterol       Date:  2012-02       Impact factor: 2.423

5.  Serum pepsinogens as a gastric cancer and gastritis biomarker in South and Southeast Asian populations.

Authors:  Muhammad Miftahussurur; Langgeng Agung Waskito; Hafeza Aftab; Ratha-Korn Vilaichone; Phawinee Subsomwong; Iswan Abbas Nusi; Ari Fahrial Syam; Thawee Ratanachu-Ek; Dalla Doohan; Gontar Siregar; Yudith Annisa Ayu Rezkitha; Kartika Afrida Fauzia; Varocha Mahachai; Yoshio Yamaoka
Journal:  PLoS One       Date:  2020-04-09       Impact factor: 3.240

6.  Serum pepsinogen II levels are doubled with Helicobacter pylori infection in an asymptomatic population of 40,383 Chinese subjects.

Authors:  Hong Yu; Ying Liu; Shujing Jiang; Yunfeng Zhou; Zheng Guan; Siyuan Dong; Fong-Fong Chu; Chunbo Kang; Qiang Gao
Journal:  Medicine (Baltimore)       Date:  2021-07-09       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.